切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - DREADD Ligands - RSK - Free Fatty Acid Receptors - D4 Receptors

10 件产品

每页
清除全部
  1. ACTB-1003
    B4904 ACTB-1003
    Target: VEGFR|FGFR|Tie-2|RSK|p70 S6K
    Summary: FGFR1抑制剂
      ≥18.15 mg/mL
      insoluble in H2O
  2. AH 7614
    B7792 AH 7614
     1 Citation
    Target: Free Fatty Acid Receptors
    Summary: FFA4/GPR120拮抗剂
      ≥35.1 mg/mL
      insoluble in H2O
  3. GSK269962A
    B3392 GSK269962A
    Target: ROCK|RSK|MSK
    Summary: ROCK抑制剂
      Soluble in DMSO
  4. Pramipexole
    B1488 Pramipexole
    中文名: 普拉克索
    Target: D2 Receptors|D3 Receptors|D4 Receptors
    Summary: 多巴胺激动剂
      ≥10.57 mg/mL
      insoluble in H2O
  5. Clozapine
    B2235 Clozapine
    中文名: 氯氮平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 Receptors
    Summary: 5-HT受体拮抗剂
      ≥14.95 mg/mL
      insoluble in H2O
  6. A-674563
    A8616 A-674563
    Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK
    Summary: Akt1 / PKA / CDK2的强效选择性抑制剂
      ≥4.9 mg/mL
      ≥23.8 mg/mL
  7. Thioridazine HCl
    A8537 Thioridazine HCl
    中文名: 盐酸硫利达嗪,盐酸硫代利哒,甲硫达嗪盐酸盐,甲硫哒嗪盐酸盐
    Target: Cytochrome P450 (CYP450)|D1 and D5 Receptors|D2 Receptors|D3 Receptors|D4 Receptors
    Summary: 钙通道蛋白抑制剂
      ≥20.35 mg/mL
      ≥6.78 mg/mL
  8. GW9508
    A1709 GW9508
    Target: Free Fatty Acid Receptors
    Summary: FFA1/GPR40激动剂
      ≥16.05 mg/mL
      insoluble in H2O
  9. TUG-770
    A3895 TUG-770
    Target: Free Fatty Acid Receptors
    Summary: FFA1/GPR40激动剂
      ≥11.85 mg/mL
      insoluble in H2O
  10. Clozapine N-oxide(CNO)
    A3317 Clozapine N-oxide(CNO)
     1 Citation
    中文名: 氯氮平的N-氧化物
    Target: DREADD Ligands
    Summary: Clozapine代谢产物,用于化学遗传学
      ≥17.15 mg/mL
      ≥49 mg/mL

10 件产品

每页